Tissue-specific increases in 11β-hydroxysteroid dehydrogenase Type 1 in normal weight postmenopausal women

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Andersson, Therése ^a   Simonyte, Kotryna ^a   Andrew, Ruth ^b   Strand, Magnus ^a   Burén, Jonas ^a   Walker, Brian R ^b   Mattsson, Cecilia ^a   Olsson, Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 5ALPHA TETRAHYDROCORTISOL; 5BETA TETRAHYDROCORTISOL; CORTISONE; HYDROCORTISONE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; UNCLASSIFIED DRUG; AROMATASE; CORTICOSTEROID; LIPID; MESSENGER RNA;

ADULT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIRST PASS EFFECT; FOLLICULAR PHASE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; LIVER; LUTEAL PHASE; POSTMENOPAUSE; PREMENOPAUSE; SUBCUTANEOUS FAT; TISSUE SECTION; TISSUE SPECIFICITY; UPREGULATION; ADIPOSE TISSUE; ANTIBODY SPECIFICITY; BLOOD; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SUBCUTANEOUS TISSUE; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ADRENAL CORTEX HORMONES; ADULT; AROMATASE; BODY WEIGHT; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIPIDS; LIVER; MIDDLE AGED; ORGAN SPECIFICITY; POSTMENOPAUSE; RNA, MESSENGER; SUBCUTANEOUS TISSUE;

EID: 77949495933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008475     Document Type: Article

References (42)

1. Bjorkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C (1996) Reproductive history in relation to relative weight and fat distribution. Int J Obes Relat Metab Disord 20: 213-219.
2. Shen W, Punyanitya M, Silva AM, Chen J, Gallagher D, et al. (2009) Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study. Nutr Metab (Lond) 6: 17.
3. Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88: 2404-2411.
4. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, et al. (2005) Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366: 1640-1649.
5. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587.
6. Walker BR, Andrew R (2006) Tissue production of cortisol by 11beta- hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann N Y Acad Sci 1083: 165-184.
7. Seckl JR, Morton NM, Chapman KE, Walker BR (2004) Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 59: 359-393.
8. Mattsson C, Reynolds RM, Simonyte K, Olsson T, Walker BR (2009) Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men. J Clin Endocrinol Metab 94: 1347-1352.
9. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, et al. (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87: 3330-3336.
10. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, et al. (2004) Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 eta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53: 931-938.
11. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, et al. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294: 2166-2170.
12. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, et al. (2003) Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112: 83-90.
13. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, et al. (2004) Metabolic syndrome without obesity: Hepatic overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 101: 7088-7093.
14. Kalleinen N, Polo-Kantola P, Irjala K, Porkka-Heiskanen T, Vahlberg T, et al. (2008) 24-hour serum levels of growth hormone, prolactin, and cortisol in pre- and postmenopausal women: the effect of combined estrogen and progestin treatment. J Clin Endocrinol Metab 93: 1655-1661.
15. Finken MJ, Andrews RC, Andrew R, Walker BR (1999) Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases. J Clin Endocrinol Metab 84: 3316-3321.
16. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR (1999) Interactions between oestradiol and glucocorticoid regulatory effects on liver- specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11beta-hydroxysteroid dehydrogenase type 1. J Endocrinol 160: 103-109.
17. Low SC, Chapman KE, Edwards CR, Wells T, Robinson IC, et al. (1994) Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J Endocrinol 143: 541-548.
18. Nwe KH, Hamid A, Morat PB, Khalid BA (2000) Differential regulation of the oxidative 11beta-hydroxysteroid dehydrogenase activity in testis and liver. Steroids 65: 40-45.
19. Gabrielsson BG, Olofsson LE, Sjogren A, Jernas M, Elander A, et al. (2005) Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 13: 649-652.
20. Livingstone DE, Jones GC, Smith K, Jamieson PM, Andrew R, et al. (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141: 560-563.
21. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, et al. (2001) Tissue- specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86: 1418-1421.
22. Best R, Nelson SM, Walker BR (1997) Dexamethasone and 11-dehydrodex- amethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo. J Endocrinol 153: 41-48.
23. Dubuc PU (1974) Effects of estradiol implants on body weight regulation in castrated and intact female rats. Endocrinology 95: 1733-1736.
24. Genazzani AR, Gambacciani M (2006) Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol 22: 145-150.
25. Dieudonne MN, Sammari A, Dos Santos E, Leneveu MC, Giudicelli Y, et al. (2006) Sex steroids and leptin regulate 11beta-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities. J Steroid Biochem Mol Biol 99: 189-196.
26. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, et al. (2004) Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 12: 9-17.
27. Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, et al. (2008) Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expres- sion in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring) 16: 731-735.
28. Misso ML, Jang C, Adams J, Tran J, Murata Y, et al. (2005) Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause 12: 210-215.
29. Zhao Y, Mendelson CR, Simpson ER (1995) Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorti- coids in adipose stromal cells and fetal hepatocytes. Mol Endocrinol 9: 340-349.
30. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, et al. (2004) 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25: 831-866.
31. Pfeilschifter J, Koditz R, Pfohl M, Schatz H (2002) Changes in proinflammatory cytokine activity after menopause. Endocr Rev 23: 90-119.
32. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, et al. (2001) Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142: 1982-1989.
33. Johansson A, Andrew R, Forsberg H, Cederquist K, Walker BR, et al. (2001) Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy. J Clin Endocrinol Metab 86: 4276-4283.
34. Andrew R, Smith K, Jones GC, Walker BR (2002) Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J Clin Endocrinol Metab 87: 277-285.
35. Andersson T, Soderstrom I, Simonyte K, Olsson T (2009) Estrogen Reduces 11beta-Hydroxysteroid Dehydrogenase Type 1 in Liver and Visceral, but Not Subcutaneous, Adipose Tissue in Rats. Obesity (Silver Spring) in press.
36. Lee MJ, Fried SK, Mundt SS, Wang Y, Sullivan S, et al. (2008) Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) 16: 1178-1185.
37. Li X, Lindquist S, Chen R, Myrnas T, Angsten G, et al. (2007) Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Int J Obes (Lond) 31: 820-828.
38. McKenzie J, Fisher BM, Jaap AJ, Stanley A, Paterson K, et al. (2006) Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin Endocrinol (Oxf) 65: 40-44.
39. Simonyte K, Rask E, Naslund I, Angelhed JE, Lonn L, et al. (2009) Obesity Is Accompanied by Disturbances in Peripheral Glucocorticoid Metabolism and Changes in FA Recycling. Obesity (Silver Spring) 17: 1982-1987.
40. Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, et al. (2007) Deep subcutaneous adipose tissue: a distinct abdominal adipose depot. Obesity (Silver Spring) 15: 1933-1943.
41. Veilleux A, Rheaume C, Daris M, Luu-The V, Tchernof A (2009) Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women. J Clin Endocrinol Metab 94: 3550-3557.
42. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC (1993) The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 23: 466-473.